Evaluation of a gamified augmented reality app as part of a multiple baseline study in people with phobias

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00033470

Enrollment

Registered

2024-01-31

Start date

2024-02-12

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F40

Interventions

Group 1: As part of a multiple baseline study, people with phobias will briefly visit their anxiety situation on five consecutive dates. The adaptive AR attention task is then randomized to be complet

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Presence of a phobic disorder

Exclusion criteria

Exclusion criteria: Presence of schizophrenia or delusional disorder treatment with electroconvulsive therapy during or one month prior to the study severely impaired vision

Design outcomes

Primary

Measure	Time frame
The primary endpoint is the subjectively experienced level of anxiety (recorded at all five measurement times) on a scale from 0 to 100).	—

Secondary

Measure	Time frame
The following standardized anxiety questionnaires will be administered before the first and after the fifth appointment: Body Sensations Questionnaire (BSQ) Anxiety Sensitivity Index (ASI-3) Agoraphobia Cognition Scale (ACS). In addition, the current depressive symptoms are to be recorded using the following self rating and externalratimg scales: Beck Depression Inventory II (BDI-II) Montgomery-Åsberg Depression Rating Scale (MADRS)	—

Measure

Time frame

The following standardized anxiety questionnaires will be administered before the first and after the fifth appointment: Body Sensations Questionnaire (BSQ) Anxiety Sensitivity Index (ASI-3) Agoraphobia Cognition Scale (ACS). In addition, the current depressive symptoms are to be recorded using the following self rating and externalratimg scales: Beck Depression Inventory II (BDI-II) Montgomery-Åsberg Depression Rating Scale (MADRS)

—

Countries

Germany

Contacts

Public ContactWolfgang Trapp

Sozialstiftung Bamberg, Klinik für Psychiatrie und Psychotherapie

wolfgang.trapp@sozialstiftung-bamberg.de+49 951 50326123

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026